Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095019

Director acquired 500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
HENNEMAN JOHN B III Director 2023-08-23 Grant or award +500 1,279 D
Derivatives
HENNEMAN JOHN B III Director 2023-08-23 Grant or award · Stock Options (Right to Buy) +2,000 2,000 D
Loading xslF345X05/tm2324788-6_4seq1.xml…